Medicenna Therapeutics Corp. (MDNAF)
Market Open
19 Dec, 15:25
NASDAQ NASDAQ Primary $
0. 75
-0.04
-4.6%
$
10.93M Market Cap
- P/E Ratio
0% Div Yield
75,100 Volume
- Eps
$ 0.78
Previous Close Day Range
0.75 0.77
Year Range
0.57 1.43
Want to track MDNAF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 55 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| MDNAF Medicenna Therapeutics Corp. 12 Feb 2026 (In 1 month) | | - | - |
| MDNAF Medicenna Therapeutics Corp. 14 Nov 2025 | | - | - |
| MDNAF Medicenna Therapeutics Corp. 25 Jun 2025 | | - | 0.01 |
| MDNAF Medicenna Therapeutics Corp. 12 Feb 2025 | | - | - |
| MDNAF Medicenna Therapeutics Corp. 12 Nov 2024 | | - | - |
| MDNAF Medicenna Therapeutics Corp. 27 Sep 2024 | | - | - |
| MDNAF Medicenna Therapeutics Corp. 2 Aug 2024 | | - | - |
| MDNAF Medicenna Therapeutics Corp. 25 Jun 2024 | | - | - |
MDNAF Earnings Reports FAQ
What is the earnings per share (EPS) for MDNAF?
EPS data for MDNAF is currently not available, as Medicenna Therapeutics Corp has not reported recent earnings.
What is the company's earnings growth rate?
Medicenna Therapeutics Corp has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-12, based on the MDNAF's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Medicenna Therapeutics Corp are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for MDNAF at this time, as Medicenna Therapeutics Corp has no recent EPS data to calculate it.
